BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2505011)

  • 1. Antibody production to a meningococcal outer membrane protein cloned into liv Salmonella typhimurium aroA vaccine strain.
    Tarkka E; Muotiala A; Karvonen M; Saukkonen-Laitinen K; Sarvas M
    Microb Pathog; 1989 May; 6(5):327-35. PubMed ID: 2505011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain.
    Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW
    Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
    Tappero JW; Lagos R; Ballesteros AM; Plikaytis B; Williams D; Dykes J; Gheesling LL; Carlone GM; Høiby EA; Holst J; Nøkleby H; Rosenqvist E; Sierra G; Campa C; Sotolongo F; Vega J; Garcia J; Herrera P; Poolman JT; Perkins BA
    JAMA; 1999 Apr; 281(16):1520-7. PubMed ID: 10227322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity.
    Nurminen M; Butcher S; Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Runeberg-Nyman K; Sarvas M; Mäkelä PH
    Mol Microbiol; 1992 Sep; 6(17):2499-506. PubMed ID: 1406285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.
    Wright JC; Williams JN; Christodoulides M; Heckels JE
    Infect Immun; 2002 Aug; 70(8):4028-34. PubMed ID: 12117908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.
    Su GF; Brahmbhatt HN; Wehland J; Rohde M; Timmis KN
    Infect Immun; 1992 Aug; 60(8):3345-59. PubMed ID: 1639503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
    Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of meningococcal outer membrane protein vaccines solubilized with detergent or C polysaccharide.
    Poolman JT; Timmermans HA; Hopman CT; Teerlink T; Van Vught PA; Witvliet MH; Beuvery EC
    Antonie Van Leeuwenhoek; 1987; 53(6):413-9. PubMed ID: 3130780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
    Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
    Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
    Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
    Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium.
    Gentry-Weeks CR; Hultsch AL; Kelly SM; Keith JM; Curtiss R
    J Bacteriol; 1992 Dec; 174(23):7729-42. PubMed ID: 1447140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.
    Martin D; Cadieux N; Hamel J; Brodeur BR
    J Exp Med; 1997 Apr; 185(7):1173-83. PubMed ID: 9104804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
    Hou VC; Koeberling O; Welsch JA; Granoff DM
    J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
    Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
    Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein.
    Van Der Ley P; Poolman JT
    Infect Immun; 1992 Aug; 60(8):3156-61. PubMed ID: 1639486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.